For many across the United States, 2020 and 2021 have brought new and different healthcare experiences than ever before. For the first time, many patients visited providers virtually, utilized mail order pharmacy services, or used an app to navigate their health records online instead of in person – and such novel approaches to care delivery are shaping the “new normal” of healthcare. Patients are no longer passive participants in their health, instead demanding transparency, convenience, access, and personalized products and services. This panel will discuss how providers, payers, policymakers and healthcare innovators will continue to support the changing landscape and will highlight the main challenges and constraints the industry must confront to create a positive patient experience.

Moderator

Sonny Goyal

Senior Vice President, Diversified Business Group and Chief Strategy Officer for Blue Cross Blue Shield of North Carolina

Speakers

Rasu Shrestha

Chief Strategy Officer at Atrium Health

Nirav Shah

Chief Medical Officer at Sharecare

Lauren Coyle

Division Vice President at DeVita Kidney Care

Technologies such as artificial intelligence (AI), machine learning, natural language processing and more are allowing businesses to fundamentally revamp operations and product development. Across healthcare, these advancements are enabling businesses to better address challenges and contribute to more personalized care. In response to these trends, traditional healthcare entities are investing in their digital capabilities internally, through collaboration or M&A. At the same time, the “Big Four” technology companies are also accelerating their pursuit of the healthcare market with different focuses, ranging from cloud services, clinical research via wearables and AI in precision medicine to new models of pharmacy and virtual care. This panel will explore the outcomes, improvements and barriers these companies face in working to ensure innovation meets patient needs.

Moderator

Stephanie Winans

Chief Growth Officer at BioDigital

Speakers

Heather Cox

Chief Digital Health & Analytics Officer at Humana

Alex Vannoni

Chief Digital Officer at Well

Brent Lamm

Senior Vice President and Deputy CIO at UNC Health

Amid a chaotic year both nationally and globally due to the ongoing COVID-19 pandemic and follow-on effects, private equity deals in healthcare have shown impressive resilience. According to recent research and analysis, healthcare PE deals continue to outpace all other deals – both in volume and value – with the majority of activity focused on the healthcare provider space and biopharmaceutical companies. As total healthcare deal value continues to grow, this panel will pause to explore critical questions about how the growth in PE-backed healthcare companies affects patients – including their health outcomes, their medical bills and their access to important health services.

Moderator

Shailesh Maingi

Founder and CEO at Inceptor Bio

Speakers

Barak Richman

Katherine T. Bartlett Professor of Law and Professor of Business Administration, Duke University

Ben Lundin

Chief Strategy Officer at Advantia Health

Jack Feltz

Chief Medical Executive Officer at Unified Women’s Healthcare

Healthcare companies across the board have started to center health equity and well-being in their strategic plans and business models. This represents a significant shift, as historically, the burden of population health has fallen to state and local health departments and community organizations. But as more healthcare corporations seek to change health outcomes based on drivers of health, how are they managing to turn value statements into practice? This panel will discuss how various companies have taken on the responsibility to practice health and well-being among the populations they serve – including their employees, their communities and their consumers.

Moderator

Pearce Weaver

Senior Vice President, Benefits Consulting at Fidelity Investments

Speakers

Rajni Dronamraju

Senior Director of Corporate Charitable Giving at Genentech

Stefanie Simmons

Vice President of Patient and Clinician Engagement at Envision Physician Services

Anita Bachmann

CEO UnitedHealth Community Plan – North Carolina at UnitedHealth Group

Healthcare in the United States is a perpetually polarizing topic. On one hand, the pandemic showcased how the private and public sectors can work together to advance medicine and save lives. On the other hand, the period shone a spotlight on a number of shortcomings and failures in business and government that fundamentally altered the public perception of the healthcare industry. This panel will discuss how various healthcare sectors can work collaboratively to end the pandemic, leverage COVID-19 as a catalyst to show a renewed commitment to patient health and discuss strategies for regaining trust from the public.

Moderator

Stephanie Mahin

Clinical Assistant Professor at UNC Kenan-Flagler Business School

Speakers

John Wiesman

Professor of the Practice at UNC Gillings School of Global Public Health

Adrienne Parrish Fuentes

Director, Global Health Policy at Thermo Fisher Scientific

Mayra Alvarez

President at The Children’s Partnership